Login
Join
FOLLOW:
Subscribe Free
Magazine
eNewsletter
Checkout
Menu
Magazine
News
Manufacturing
Packaging
Development
Compliance
Top 20
Directory
Solution Center
Events
More
Magazine
News
Manufacturing
Packaging
Development
Compliance
Top 20
Directory
Solution Center
Events
Current / Back Issue
Features
Editorial
Columns
Digital Edition
eNewsletter Archive
Our Team
Editorial Guidelines
Subscribe Now
Advertise Now
Top Features
CEO Spotlight: Gaston Salinas
Single-use Fermenters for Microbial Biopharma Development & Manufacturing
Creating Solutions for CDMOs: An EPCMV Firm’s Perspective
The Transformative Potential of Gene Therapy
Parenteral Perspectives
Breaking News
Online Exclusives
Industry News
Collaborations & Alliances
Promotions & Moves
Trials & Filings
Financial Reports
Bio News & Views
Custom Sourcing News
Packaging & Tracking
CRO News
Live From Shows
Top News
Aurigene Pharmaceutical Services Opens Biologics Facility
AGC Biologics Completes Copenhagen Campus Expansion
CordenPharma, Certest Partner on Ionizable Lipids in LNP Formulation
Syngene Launches Platform for Enhanced Protein Production
Aragen Bioscience Validates Getinge’s Single-Use Production Reactor
APIs
Aseptic Processing
Cleaning Validation
Clinical Trial Materials
Cytotoxics and High Potency Manufacturing
Equipment
Excipients
Extractables and Leachables
Facilities
Fill/Finish
Lyophilization
Parenterals
Process Development
Process Validation
Risk Management
Scale-up/ Technology Transfer
Solid Dosage/ Creams/ Ointments
Aurigene Pharmaceutical Services Opens Biologics Facility
AGC Biologics Completes Copenhagen Campus Expansion
Aragen Bioscience Validates Getinge’s Single-Use Production Reactor
Ecolab, Repligen Launch DurA Cycle Affinity Resin for Large-Scale Biologic Mfg.
Vetter to Expand Capacity in the U.S. and Germany
Capsules
Cold Chain Management
Injectables
Logistics
Serialization
Solid Dosage / Semi-solids
Supply Chain
Vials
Thermo Fisher Opens New GMP Ultra-cold Facility in the EU
The Future of the Pharmaceutical Contract Packaging Industry
PDUFA to Patients in 7 Days with Integrated Packaging Solutions
Pharma Matters Q&A: PCI Pharma Services
Pharma Matters Q&A: Marken
Analytical Services
Bioanalytical Services
Bioassay Developement
Biologics, Proteins, Vaccines
Biosimilars
Chemistry
Clinical Trials
Drug Delivery
Drug Development
Drug Discovery
Formulation Development
Information Technology
Laboratory Testing
Methods Development
Microbiology
Preclinical Outsourcing
R&D
Toxicology
Aurigene Pharmaceutical Services Opens Biologics Facility
AGC Biologics Completes Copenhagen Campus Expansion
CordenPharma, Certest Partner on Ionizable Lipids in LNP Formulation
Syngene Launches Platform for Enhanced Protein Production
Ecolab, Repligen Launch DurA Cycle Affinity Resin for Large-Scale Biologic Mfg.
Filtration & Purification
GMPs/GCPs
Inspections
QA/QC
Regulatory Affairs
Validation
How QMS Impacts Quality Maturity
Regulatory Affairs: Drug Shortages – No Solution in Sight!
Regulatory Affairs: A Common Warning Letter Citation Explored
The Future of Pharmacovigilance is Proactive
Parenteral Perspectives
Companies
Categories
Corporate Capabilities
Add New Company
Contract Service Directory Companies
AMERIPHARMA
INCOG BioPharma Services
Lannett CDMO
SUANFARMA CDMO
TaiMed Biologics
Companies
News Releases
Posters
Brochures
Services
Videos
Case Study
White Papers
Jobs
Contract Service Directory Companies
AMERIPHARMA
INCOG BioPharma Services
Lannett CDMO
SUANFARMA CDMO
TaiMed Biologics
Webinars
Live From Shows
Magazine
Current / Back Issue
Features
Editorial
Columns
Editorial Guidelines
Subscribe Now
Advertise Now
Enewsletter Archive
Digital Edition
Directory
Companies
Categories
Corporate Capabilities
Add Your Company
Manufacturing
APIs
Aseptic Processing
Cleaning Validation
Clinical Trial Materials
Cytotoxics and High Potency Manufacturing
Equipment
Excipients
Extractables and Leachables
Facilities
Fill/Finish
Lyophilization
Parenterals
Process Development
Process Validation
Risk Management
Scale-up/ Technology Transfer
Solid Dosage/ Creams/ Ointments
cGMP Manufacture
Packaging
Capsules
Cold Chain Management
Injectables
Logistics
Serialization
Solid Dosage / Semi-solids
Supply Chain
Vials
Development
Analytical Services
Bioanalytical Services
Bioassay Developement
Biologics, Proteins, Vaccines
Biosimilars
Chemistry
Clinical Trials
Drug Delivery
Drug Development
Drug Discovery
Formulation Development
Information Technology
Laboratory Testing
Methods Development
Microbiology
Preclinical Outsourcing
R&D
Toxicology
Compliance
Filtration & Purification
GMPs/GCPs
Inspections
QA/QC
Regulatory Affairs
Validation
Top 20 Pharma & BioPharma
Contract Pharma Direct
Breaking News
Online Exclusives
Slideshows
Experts Opinions
Surveys
Outsourcing Survey
Salary Survey
Glossary
Videos
White Papers
Podcasts
Infographics
Microsites
Companies
News Releases
Posters
Brochures
Services
Videos
Case Study
White Papers
Contract Pharma Conference
Contract Pharma Conference
Speakers
Exhibitors
Conference Sessions
eBook
Webinars
Events
Industry Events
Live from Show Events
Webinars
Classifieds / Job Bank
Classifieds
Job Bank
About Us
About Us
Contact Us
Advertise With Us
Privacy Policy
Terms of Use
Drug Development
Editorial
All
Analytical Services
Bioassay Development
Biologics, Proteins, Vaccines
Biosimilars
Chemistry
Clinical Trials
Drug Delivery
Drug Development
Drug Discovery
Information Technology
Laboratory Testing
Methods Development
Microbiology
Preclinical Outsourcing
R&D
Toxicology
Biologics, Proteins, Vaccines
|
Breaking News
|
Drug Development
|
Industry News
Syngene Launches Platform for Enhanced Protein Production
New platform is designed to streamline clone selection and enhance operational productivity.
06.06.24
Breaking News
|
cGMP Manufacture
|
Drug Development
|
Industry News
AstraZeneca Invests in Nucleus RadioPharma
Nucleus working to expand development, supply, and commercial manufacturing capabilities to make targeted radiotherapies and theranostics more accessible.
06.05.24
Breaking News
|
Drug Development
|
Industry News
Lilly Licenses QurAlis’ ALS Precision Therapy for $45M Upfront
QRL-204 designed to restore UNC13A function in amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases.
06.03.24
Analytical Services
|
Drug Development
|
Extractables and Leachables
Why Are Uncertainty Factors and RRF Databases Important When Selecting an E&L Provider?
Element senior scientist, Kristin Treece, explores how optimizing RRFs directly impacts the complexity and cost of your E&L studies.
06.03.24
Biologics, Proteins, Vaccines
|
Breaking News
|
Collaborations & Alliances
|
Drug Development
ProBioGen Partners with ModeX to Accelerate COVID-19 Antibody Development
Collaboration encompasses a full spectrum of services, including cell line development, process optimization & large-scale GMP production.
05.30.24
Bio News
|
Breaking News
|
Clinical Trials
|
Drug Development
J&J to Acquire Rights to Investigational Bispecific Antibody
Enters agreement with Numab Therapeutics to acquire the global rights to NM26, which targets 2 clinically proven pathways in atopic dermatitis.
05.29.24
Breaking News
|
Drug Development
|
Industry News
Merck Agrees to Acquire EyeBio
Aims to advance the development of EyeBio’s pipeline of candidates targeting retinal diseases.
05.29.24
Biologics, Proteins, Vaccines
|
Drug Development
Gene Therapy is Having its Moment: Can the Clinical Research Ecosystem Seize It?
Address risks without limiting innovation and ensure trial development process aligns with clinical needs and regulatory standards.
James Riddle, Senior Vice President, Global Review Operations, Advarra
05.29.24
Biologics, Proteins, Vaccines
|
Breaking News
|
Collaborations & Alliances
|
Drug Delivery
|
Drug Development
RevolKa Signs Master Service Agreement with Daiichi Sankyo
Will create and deliver functional proteins in collaboration with Daiichi Sankyo by using its protein engineering platform technology.
05.28.24
Breaking News
|
Collaborations & Alliances
|
Drug Development
HanAll Signs Exclusive Licensing Agreement with Turn Biotechnologies
The terms grant HanAll the right to utilize Turn Bio's Epigenetic Reprogramming of Aging (ERATM) technology.
05.28.24
Breaking News
|
Collaborations & Alliances
|
Drug Development
|
Drug Discovery
Degron Enters Collaboration & License Agreement with Takeda
Will discover and develop novel molecular glue degraders for multiple targets in oncology, neuroscience, and inflammation.
05.23.24
Breaking News
|
Drug Development
|
Industry News
MilliporeSigma Agrees to Acquire Mirus Bio for $600M
Mirus Bio develops & commercializes transfection reagents, which play a critical role in the production of viral vector-based gene therapies.
05.23.24
Breaking News
|
cGMP Manufacture
|
Collaborations & Alliances
|
Drug Development
AGC Biologics, BioConnection Partner to Provide End-to-End Biopharma Development & Manufacturing
New partnership offers a seamless, full-service clinical-stage development and manufacturing solution.
05.22.24
Bio News
|
Breaking News
|
Drug Development
|
Industry News
Biogen Agrees to Acquire HI-Bio for $1.15B
HI-Bio’s lead asset, felzartamab, is a monoclonal antibody with potential to improve clinical outcomes in a broad range of immune-mediated diseases.
05.22.24
Breaking News
|
Collaborations & Alliances
|
Drug Development
|
Drug Discovery
Medigene & BioNTech Extend T Cell Receptor Immunotherapy Collaboration
Will enable ongoing and future work required to potentially generate novel TCRs directed against multiple newly nominated antigen targets.
05.21.24
Breaking News
|
Collaborations & Alliances
|
Drug Development
Astellas, Yaskawa Discuss Potential Creation of Innovative Cell Therapy Ecosystem
Aim to seamlessly link early-stage research to commercialization to manufacture high-quality products and shorten the R&D period of cell therapy.
05.21.24
Biologics, Proteins, Vaccines
|
Breaking News
|
Collaborations & Alliances
|
Drug Development
TFF Pharmaceuticals, Cleveland Clinic to Advance Multiple Influenza Vaccines
Aim to develop a first-in-class, stable, universal, easy-to-transport and easy-to-stockpile vaccine.
05.20.24
Bio News
|
Breaking News
|
Collaborations & Alliances
|
Drug Development
Siren Biotechnology, Catalent Partner for Manufacturing of AAV Gene Therapies
Catalent to support the development and manufacturing of Siren Biotechnology’s AAV immuno-gene therapies for cancer.
05.17.24
Bio News
|
Breaking News
|
Drug Development
|
Drug Discovery
|
Promotions & Moves
Regulus Therapeutics Names New Chief Medical Officer
Dr. Rekha Garg is a physician executive with over 20 years of experience in leadership roles in the biopharma industry.
05.16.24
Bio News
|
Breaking News
|
Collaborations & Alliances
|
Drug Development
FogPharma, ARTBIO Partner to Develop Helicon-Enabled ARTs (HEARTs)
Aim to transform outcomes for patients with multiple types of cancer.
05.14.24
Breaking News
ReiThera Appoints Stefano Colloca CEO
SCHOTT Pharma, KORU Medical Systems Partner on Drug Delivery System
Aurigene Pharmaceutical Services Opens Biologics Facility
AGC Biologics Completes Copenhagen Campus Expansion
CordenPharma, Certest Partner on Ionizable Lipids in LNP Formulation
View Breaking News >
CURRENT ISSUE
May 2024
CDMOs: The Cornerstone of Biopharmaceutical Innovation
Pharma 4.0: CDMOs Digitalize to Enhance Customer Value
CEO Spotlight: Gaston Salinas
Parenteral Perspectives
The Transformative Potential of Gene Therapy
Cell & Gene Therapy Outsourcing
Creating Solutions for CDMOs: An EPCMV Firm’s Perspective
Single-use Fermenters for Microbial Biopharma Development & Manufacturing
View More >